Evidence map›Paper›PMID 41884771›Full record

ArticleKidney medicine2026

Triple-Positive Serology in Rapidly Progressive Glomerulonephritis: A Diagnostic Dilemma.

Nisha Godbole, Mahesh Tiwari, Pooja Jotwani, Jyoti Verma, Jammie Law, David Roofeh, Alex Plamm, Marie-Claire Maroun

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nisha GodboleDepartment of Internal Medicine, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
Mahesh TiwariDepartment of Internal Medicine, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
Pooja JotwaniDepartment of Internal Medicine, Division of Rheumatology and Connective Tissue, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
Jyoti VermaDepartment of Internal Medicine, Division of Rheumatology and Connective Tissue, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
Jammie LawDepartment of Internal Medicine, Division of Rheumatology and Connective Tissue, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
David RoofehDepartment of Internal Medicine, Division of Rheumatology and Connective Tissue, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.
Alex PlammDivision of Nephrology, Robert Wood Johnson University Hospital, Rutgers University, New Brunswick, NJ.
Marie-Claire MarounDepartment of Internal Medicine, Division of Rheumatology and Connective Tissue, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acute onset of malignant hypertension and acute kidney injury in patients with features suggestive of systemic sclerosis often raises concern for scleroderma renal crisis, a life-threatening complication requiring prompt recognition and angiotensin-converting enzyme inhibitor therapy. However, other autoimmune vasculitides, including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and antiglomerular basement membrane (anti-GBM) disease, can present similarly but require immunosuppressive therapy. We reported a diagnostically challenging case of a 72-year-old woman with interstitial lung disease, Raynaud's phenomenon, and serologic findings of antitopoisomerase I antibody and antimyeloperoxidase (p-ANCA) antibodies. Given this clinical picture, scleroderma renal crisis was initially suspected. However, a kidney biopsy revealed pauci-immune necrotizing and crescentic glomerulonephritis with uniform crescents and without linear IgG deposition along the GBM. Given the uniformity of crescents, additional serologic testing revealed elevated anti-GBM antibody levels, posing a therapeutic dilemma regarding the presence of clinically significant anti-GBM disease in the absence of immunofluorescence confirmation. This case highlighted the critical role of early kidney biopsy in ambiguous presentations and the need for heightened awareness of overlapping autoimmune syndromes to guide timely and appropriate treatment. Systematic reporting of such overlap syndromes is essential for improving diagnostic accuracy and optimizing outcomes.

Indexed as

anti-glomerular basement membrane diseaseantineutrophil cytoplasmic antibody-associated vasculitisdual-positive diseaseRapidly progressive glomerulonephritis

Identifiers

PMID41884771
PMCPMC13010390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.